
Claudia M Denkinger MD
Instructor in Medicine, Beth Israel Deaconess Medical Center
Join to View Full Profile
110 Francis StLmob, Suite GbBoston, MA 02215
Phone+1 617-632-0766
Are you Dr. Denkinger?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Claudia Denkinger, MD is an infectious disease specialist in Boston, Massachusetts. She is an Instructor in Medicine at Beth Israel Deaconess Medical Center.
Education & Training
- Beth Israel Deaconess Medical CenterFellowship, Infectious Disease, 2010 - 2013
- Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 2005 - 2008
- University of Wurzburg Faculty of MedicineClass of 2004
Publications & Presentations
PubMed
- 1 citationsC-Reactive Protein-based Screening of People with Tuberculosis Symptoms: A Diagnostic Accuracy Study.Brigitta Derendinger, Tessa K Mochizuki, Danaida Marcelo, Deepa Shankar, Wilson Mangeni
American Journal of Respiratory and Critical Care Medicine. 2025-03-01 - 2 citationsA Prospective Evaluation of the Diagnostic Accuracy of the Point-of-Care VISITECT CD4 Advanced Disease Test in 7 Countries.Tinne Gils, Jerry Hella, Bart K M Jacobs, Bianca Sossen, Madalo Mukoka
The Journal of Infectious Diseases. 2025-02-04 - Programmatic Diagnostic Accuracy and Clinical Utility of Xpert MTB/XDR in Patients With Rifampicin-Resistant Tuberculosis in Georgia.Theresa Pfurtscheller, Ana Tsutsunava, Nino Maghradze, Mariam Gujabidze, Nino Bablishvili
Open Forum Infectious Diseases. 2025-02-01
Press Mentions
- Diagnostic Accuracy of Urine Lipoarabinomannan Testing in Early Morning Urine Versus Spot Urine for Diagnosis of Tuberculosis Among People with HIVMarch 31st, 2022
- Tuberculosis Outbreak Tied to Bone Grafts Underscores Shortcomings of TestingAugust 12th, 2023
Grant Support
- C3PO - The Candidate Clinical Correlate of Prognostic Outcome for TB StudyUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2024–2025
- Rapid Research for Diagnostics Development in TB Network (R2D2 TB Network)UNIVERSITY OF CALIFORNIA, SAN FRANCISCO2020–2025
- Rapid Research for Diagnostics Development in TB Network (R2D2 TB Network)UNIVERSITY OF CALIFORNIA, SAN FRANCISCO2020–2025